E-LIB Suche - Ergebnisse für: McAllister, Peter J.

1

Sustained response to atogepant in episodic migraine: post ..:

Lipton, Richard B. ; Nahas, Stephanie J. ; Pozo-Rosich, Patricia...
The Journal of Headache and Pain. 25 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

2

Long‐term effectiveness of eptinezumab in the treatment of ..:

Blumenfeld, Andrew ; Kudrow, David ; McAllister, Peter...
Headache: The Journal of Head and Face Pain. 64 (2024) 7 - p. 738-749 , 2024

Link: https://doi.org/10.1111/..

3

The critical role of affect regulation accounting for incre..:

Morris, Deborah J ; Webb, Elanor Lucy ; Umpunjun, Petch...
European Journal of Trauma & Dissociation. 8 (2024) 1 - p. 100374 , 2024

Link: https://doi.org/10.1016/..

4

Comparative efficacy, quality of life, safety, and tolerabi..:

Tassorelli, Cristina ; Onishchenko, Kateryna ; Halker Singh, Rashmi B....
Cephalalgia. 44 (2024) 2 - p. , 2024

Link: https://doi.org/10.1177/..

5

Impact of fremanezumab treatment on disability outcomes in ..:

Mcallister, Peter ; Campos, Verena Ramirez ; Arie, Zipora Roth-Ben...
Journal of the Neurological Sciences. 455 (2023) - p. 121660 , 2023

Link: https://doi.org/10.1016/..

6

The temporal trend of placebo response in migraine preventi..:

Tepper, Stewart J. ; Cirillo, Jessica ; Kim, Edward...
The Journal of Headache and Pain. 24 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

7

Long-term Safety of Repeat Treatments of Daxibotulinumtoxin..:

McAllister, Peter ; Jinnah, H. ; Evidente, Virgilio Gerald...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

8

Safety and tolerability results of atogepant for the preven..:

Klein, Brad C ; Miceli, Rosa ; Severt, Lawrence...
Cephalalgia. 43 (2023) 1 - p. 033310242211282 , 2023

Link: https://doi.org/10.1177/..

9

Benefit-risk assesment of atogepant: A post hoc anlysis of ..:

Nahas, Stephanie ; Ailani, Jessica ; Mcallister, Peter...
Journal of the Neurological Sciences. 455 (2023) - p. 121632 , 2023

Link: https://doi.org/10.1016/..

10

A Novel Virtual-Based Comprehensive Clinical Approach to He..:

Berk, Thomas ; Silberstein, Stephen ; McAllister, Peter
Journal of Clinical Medicine. 12 (2023) 16 - p. 5349 , 2023

Link: https://doi.org/10.3390/..

11

Benefit-Risk Assessment of Atogepant: A Post Hoc Analysis o..:

Nahas, Stephanie ; Ailani, Jessica ; McAllister, Peter...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

12

Correction: Rapid resolution of migraine symptoms after ini..:

Ailani, Jessica ; McAllister, Peter ; Winner, Paul K....
BMC Neurology. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

13

Impact of fremanezumab on disability outcomes in patients w..:

McAllister, Peter ; Cohen, Joshua M. ; Campos, Verena Ramirez...
The Journal of Headache and Pain. 23 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

14

Efficacy and safety of eptinezumab in patients with migrain..:

Ashina, Messoud ; McAllister, Peter ; Cady, Roger..
Cephalalgia. 42 (2022) 8 - p. 696-704 , 2022

Link: https://doi.org/10.1177/..

15

Five-year prospective fistula audit in a single center. TIG..:

Maciver, Rory ; Baniulyte, Gabriele ; O'Neill, Tomas B....
Journal of Plastic, Reconstructive & Aesthetic Surgery. 75 (2022) 2 - p. 806-810 , 2022

Link: https://doi.org/10.1016/..